RejuvStem Opened Manufacturing Lab Near Miami
The company expects to launch its new stem cell processing facility within the next two months.
Updated on Oct. 7, 2026 in Arthritis
Live Poll
Do you support the expansion of domestic stem cell manufacturing facilities in the United States?
RejuvStem is bringing stem cell manufacturing to the Miami area to support its expanding network of partner clinics. The company derives its supply from donated placental tissue following elective C-section deliveries.
Why it matters
Florida's current regulatory framework has created a space for the growth of stem cell therapies as demand increases among patients seeking treatments for chronic conditions. The new local lab is set to supply partner clinics across Florida, Georgia, and Tennessee.
One in four American adults currently live with chronic pain, a demographic RejuvStem aims to reach through its new manufacturing lab. The company plans to scale operations to support clinical partners across three states.
The players
RejuvStem
A stem cell therapy company currently expanding its manufacturing presence into Florida.
John Merola
The chief operating officer and a partner at RejuvStem.
Chirag Shah
The founder of RejuvStem who established the company five years ago.
The details
The facility will process stem cells for use in regenerative treatments, including the proprietary DeZawa Muse cell therapy. By centralizing manufacturing locally, RejuvStem intends to distribute biological products more efficiently to its growing network of clinical partners. The company has moved from its clinical base in Cancun to establish this domestic production hub under Florida's state-level regulatory environment.
Timeline
The Miami lab is expected to open within one to two months.
Founder Chirag Shah started the company five years ago.
RejuvStem consolidated clinical operations in Cancun two years ago.
Beyond the 305
The arrival of this lab follows the specific regulatory trajectory set by Florida's state-level framework for stem cell therapies. This growth marks a shift in how private firms are utilizing local production to meet the regional demand for regenerative treatments.
Residents seeking regenerative therapies may soon have access to products manufactured closer to home as the local lab streamlines the supply chain. Watch for the official facility opening within the next two months.
The takeaway
The addition of a local manufacturing hub signals a significant shift in how specialized biological treatments are distributed throughout the Southeast. Residents should keep an eye on clinic announcements regarding product availability and treatment updates in the coming months.
Further reading
Learn more about the latest innovations and standards for care in our Arthritis section.
Source note: This article includes information reported by Medical Daily.
Live Poll
Do you support the expansion of domestic stem cell manufacturing facilities in the United States?
